Sickle Cell Disease and Hematopoietic Stem Cell Transplantation
Springer International Publishing (Verlag)
978-3-319-87292-6 (ISBN)
Written by experts in the field, Sickle Cell Disease and Hematopoietic Stem Cell Transplantation is a valuable resource for physicians and researchers dealing with and interested in this challenging, yet exciting, curative therapy for sickle cell disease, that will help guide patient management and stimulate investigative efforts.
Emily Riehm Meier, MD, MSHS Pediatric Hematologist and Director, Sickle Cell Research, Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USA Allistair Abraham, MDChildren's National Medical Center, Division of Blood and Marrow Transplantation, Washington, DC, USA Ross M. Fasano, MDEmory University School of Medicine, Department of Pathology & Laboratory Medicine, Atlanta GA, USA
Clinical Manifestations of Sickle Cell Disease Across the Lifespan.- Pathobiology of Sickle Cell Disease Vaso-Occlusion and Targeted Therapies.- Current Non-HSCT Related Treatments for SCD.- Risk Based Therapies for Sickle Cell Disease.- Transfusion Support of the Patient with Sickle Cell Disease Undergoing Transplantation.- Neurological Manifestations of Sickle Cell Disease and Their Impact on Allogeneic Hematopoietic Stem Cell Transplantation.- Overview of Hematopoietic Stem Cell Transplantation for Non-Malignant Diseases.- Unique Challenges of Hematopoietic Stem Cell Transplant for Sickle Cell Disease.- The Ethics of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.- Psychosocial Care and Education of Children with Sickle Cell Disease undergoing Hematopoietic Stem Cell Transplant and their Families.- Long Term Effects of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.- Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.- Unrelated Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.- Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease.- Gene Therapy 101: The Path Toward Becoming a Realistic Cure for Patients with Sickle Cell Disease.
"An authoritative work on hematopoietic stem cell transplantation (HSCT) ... . Written by leading expert clinicians and researchers ... . this is a very valuable resource for clinicians and scientists dealing with this devastating disease and pursuing a curative therapy." (Ravi Salgia, Doody's Book Reviews, August, 2018)
“An authoritative work on hematopoietic stem cell transplantation (HSCT) … . Written by leading expert clinicians and researchers … . this is a very valuable resource for clinicians and scientists dealing with this devastating disease and pursuing a curative therapy.” (Ravi Salgia, Doody's Book Reviews, August, 2018)
| Erscheint lt. Verlag | 18.8.2018 |
|---|---|
| Zusatzinfo | XIII, 334 p. 21 illus., 16 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Gewicht | 718 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| Schlagworte | GVHD prophylaxis • hydroxyurea • molecular phenotyping • reduced intensity conditioning • silent cerebral infarcts • transfusional hemochromatosis |
| ISBN-10 | 3-319-87292-3 / 3319872923 |
| ISBN-13 | 978-3-319-87292-6 / 9783319872926 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
